Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.55 USD | -0.66% | -1.30% | -48.59% |
05-21 | Palisade Bio, Inc. Announces Presentation of Positive Preclinical Data from PALI-2108 | CI |
05-13 | Palisade Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.59% | 4.29M | |
+56.80% | 59.34B | |
+43.17% | 40.24B | |
-5.14% | 39.88B | |
-5.56% | 28.55B | |
+15.51% | 27.26B | |
-21.05% | 19.23B | |
+33.31% | 12.61B | |
+2.19% | 12.49B | |
+25.78% | 12.28B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Transcript : Seneca Biopharma, Inc. - Shareholder/Analyst Call